³Ô¹ÏÍøÕ¾

Latest biotechnology News | Page 9

Better treatments sooner – Hudson’s new RNAte Platform unveiled
Investing In World-First Tech For Vaccine Development
Close look at Australia’s soil profiles
Starpharma says Viraleze shows antiviral efficacy in COVID-19 patients
Arovella licences novel CARiNKT cell armouring technology
Pioneering melanoma researchers named 2024 Australian of the Year
AusBiotech members invited to capital attraction roundtable
Aravax closes funding round to accelerate development for peanut allergy therapy
Investing in ground breaking peanut allergy therapy
AVITA Medical signs US distribution agreement with Stedical Scientific
Opthea receives additional funding under development funding agreement
Chimeric Therapeutics completes placement with shortfall commitments
Hidden threat: the rise of deadly fungal pathogens
Made In Victoria: Groundbreaking Peanut Allergy Therapy
Hidden threat: rise of deadly fungal pathogens
A novel switch to turn genes on/off, promising step toward safer gene therapy
ChemPartner Unveils Highly Anticipated Biology Database
A year of Science and Engineering at The University of Manchester
Carina Biotech doses first patient in Phase 1/2a trial of LGR5-Targeted CAR-T cell therapy
Neuren Pharmaceuticals announces top-line results of Phase 2 NNZ-2591 trial
Year of collective success: 2023 in review
AusBiotech announces Acting CEO
Eggs from men, sperm from women: how stem cell science may change how we reproduce
CMAX Clinical Research preparing to celebrate three decades of continuous operations
Brooker Consulting launches two new initiative for life science sector
AusBiotech calls for journal articles 14 December
FDA grants fast-track designation for EnGeneIC’s pancreatic cancer candidate
Prescient announces the results of PTX-100 Phase 1b study in T-cell lymphoma patients
New leadership for Health Security Systems Australia
Victorian Government backs the development of Cyban’s brain injury technology
Australia’s clinical trial sector connects at AusBiotech 2023
Grants to build Australia’s Quantum pipeline
AusBiotech energised by new Board appointments
BioNTech to establish clinical-scale mRNA manufacturing facility at La Trobe University
Leibniz Prizes for two Max Planck scientists
Cynata Therapeutics secures approval for Phase 2 trial in Turkey
Microba Life Sciences announces results of successful Phase IBD trial
Telix says the first patient dosed in European early access program for TLX250-CDx
Neuren Pharmaceuticals completes enrolment in Pitt Hopkins syndrome Phase 2 trial
Australia’s Cell and Gene Catalyst calls for Expressions of Interest
Appointments to Foreign Investment Review Board
OncoSil Medical onboards first patient in the PANCOSIL clinical trial
Korean regulator approves Amplia Therapeutics’ pancreatic cancer trial
Sugar permeation discovered in plant aquaporins
University of Manchester launches new strategic partnership with Osaka University
COP28: Roundtable highlights FAO-IAEA Joint Centre’s work on nuclear techniques in food and agriculture amid climate crisis
Clarity’s theranostic prostate cancer trial progresses at the highest dose level cohort
Microba completes stage one screening for its autoimmune disease program